A new human prostate carcinoma cell line, 22Rv1-Reference-Cited by-同舟云学术

A new human prostate carcinoma cell line, 22Rv1

Published:1999-07 Issue:7 Volume:35 Page:403-409
ISSN:1071-2690
Container-title:In Vitro Cellular & Developmental Biology - Animal
language:en
Short-container-title:In Vitro Cell.Dev.Biol.-Animal

Author:

Sramkoski R. Michael,Pretlow Thomas G.,Giaconia Joseph M.,Pretlow Theresa P.,Schwartz Stuart,Sy Man-Sun,Marengo Susan R.,Rhim Johng S.,Zhang Desheng,Jacobberger James W.

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Developmental Biology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s11626-999-0115-4.pdf

Reference37 articles.

1. Barranco, M. A.; Alcaraz, A.; Corral, J. M.; Sole, M.; Mallofre, C.; Llopis, J.; Rodriguez, A.; Ribal, M. J.; Alvarez-Vijande, R.; Carretero, P. Numeric alterations in chromosomes 7 and 8 detected by fluorescent in situ hybridization correlate with high-grade localized prostate cancer. Eur. Urol. 34:419–425; 1998.

2. Brolin, J.; Skoog, L.; Ekman, P. Immunohistochemistry and biochemistry in detection of androgen, progesterone, and estrogen receptors in benign and malignant human prostatic tissue. Prostate 20:281–295; 1992.

3. Chah, J. A.; Rhim, J. S. Current status of prostate cancer research: development of in vitro model systems. Int. J. Oncol. 5:1233–1242; 1994.

4. Cheng, L.; Sun, J.; Pretlow, T. G.; Culp, J.; Yang, N. S. CWR22 xenograft as an ex vivo human tumor model for prostate cancer gene therapy. J. Natl. Cancer Inst. 88:607–611; 1996.

5. Cui, J.; Deubler, D. A.; Rohr, L. R.; Zhu, X. L.; Maxwell, T. M.; Changus, J. E.; Brothman, A. R. Chromosome 7 abnormalities in prostate cancer detected by dual-color fluorescence in situ hybridization. Cancer Genet. Cytogenet. 107:51–60; 1998.

Cited by 360 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Protective Effects of an Aged Black Garlic Water Extract on the Prostate;Nutrients;2024-09-07

2. A forward genetic screen identifies Sirtuin1 as a driver of neuroendocrine prostate cancer;2024-08-26

3. Targeting PLOD2 suppresses invasion and metastatic potential in radiorecurrent prostate cancer;BJC Reports;2024-08-21

4. Periprostatic adipose tissue inhibits tumor progression by secreting apoptotic factors: A natural barrier induced by the immune response during the early stages of prostate cancer;Oncology Letters;2024-08-08

5. Synergistic combination therapy with ONC201 or ONC206, Enzalutamide and Darolutamide in preclinical studies of castration-resistant prostate cancer;2024-08-01